Eleison Pharmaceuticals
Princeton, US · Founded 2020 · Delaware corporation
Founders & leadership
PM
Patrick MaguireChief Medical Officer
EJ
Edwin J ThomasChief Executive Officer, President and Chairman of the Board
MA
Matthew Allen CromieVice President - Clinical Research
WV
William Vincent FrickerChief Financial Officer
ME
Michael E LustyVice President - Chemistry Manufacture and Contracts
MJ
Michael J OttoNamed on SEC filing
FS
Frank SeidmanNamed on SEC filing
JM
Joel MorganrothNamed on SEC filing
BR
Bryan R WoodNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$980K disclosed across 1 round · 2022
▶$980KraisedSep 2022 · 20 investors · PharmaceuticalsRule 506(b)
▶$980KraisedSep 2022 · 20 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael J OttoDirector
- Patrick MaguireExecutive Officer
- Edwin J ThomasExecutive Officer, Director
- Matthew Allen CromieExecutive Officer
- Frank SeidmanDirector
- Joel MorganrothDirector
- William Vincent FrickerExecutive Officer
- Bryan R WoodDirector
- Michael E LustyExecutive Officer
- Offering amount
- $1M
- Amount sold
- $980K
- Minimum investment
- $25K
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Eleison Pharmaceuticals raised?
- Eleison Pharmaceuticals has disclosed $980K raised across 1 round.
- Where is Eleison Pharmaceuticals headquartered?
- Eleison Pharmaceuticals is headquartered in Princeton, US.